Hepatitis C advances in antiviral therapy: what is accepted treatment now? - Wikidata - awgldk - TriplyDB

Hepatitis C advances in antiviral therapy: what is accepted treatment now?

Hepatitis C advances in antiviral therapy: what is accepted treatment now?

http://www.wikidata.org/entity/Q34619384

about

Use of a commercially available line probe assay for genotyping of hepatitis C virus 5a strains.Hematologic disorders associated with hepatitis C virus infection and their management.RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells Hepatitis C virus therapies: current treatments, targets and future perspectives.Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations.Peginterferon alfa-2a is superior to peginterferon alfa-2b in the treatment of naïve patients with hepatitis C virus infection: meta-analysis of randomized controlled trials.Estimation of inhibitory quotient using a comparative equilibrium dialysis assay for prediction of viral response to hepatitis C virus inhibitors.

P2860

Q27472773-CC95FDE8-386F-45F6-B5EF-B0FB3E885EAB Q33349378-FC26C807-D387-4CA8-BFFD-CF529C45AA0B Q34178401-AE2A19C4-165F-4235-97F1-0D093D9233FF Q35147050-03314AC7-AA85-4C26-8F5B-9BDE54DCFF98 Q35873867-19203009-671D-433F-BD31-7A1F6E3445E1 Q37885222-6E7ED61A-381B-4248-A109-58741027A420 Q39705689-1AEBF4ED-1945-436E-8D36-65732C2C38E7

P2860

Hepatitis C advances in antiviral therapy: what is accepted treatment now?

http://www.wikidata.org/entity/Q34619384

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Hepatitis C advances in antiviral therapy: what is accepted treatment now?

@ast

Hepatitis C advances in antiviral therapy: what is accepted treatment now?

@en

Hepatitis C advances in antiviral therapy: what is accepted treatment now?

@nl

type

label

Hepatitis C advances in antiviral therapy: what is accepted treatment now?

@ast

Hepatitis C advances in antiviral therapy: what is accepted treatment now?

@en

Hepatitis C advances in antiviral therapy: what is accepted treatment now?

@nl

prefLabel

Hepatitis C advances in antiviral therapy: what is accepted treatment now?

@ast

Hepatitis C advances in antiviral therapy: what is accepted treatment now?

@en

Hepatitis C advances in antiviral therapy: what is accepted treatment now?

@nl

P1433

Q34619384-FD367018-DC4C-4A52-BBDB-1E54992A29B4

P1476

Q34619384-A649DA8B-723C-40FC-8A6D-EA794B08CF2B

P2093

Q34619384-B8E2B9F9-F130-4EC2-A527-6BB8A1B72843

P2860

Q34619384-0FB09893-913F-4F0B-9E79-9576734460C5

Q34619384-16905D71-02B9-4F16-84B8-EBF47BEA3FA5

Q34619384-19215B31-B7EF-4A5C-9E3A-96CF4B8D6BFA

Q34619384-1BD3C0A4-3E59-4667-ACB9-DDC9CD16624E

Q34619384-1E342837-EEA2-466E-B718-F809ABE0A8BC

Q34619384-1F7DA7BE-1860-4AD2-AE11-B4AE16A4AA39

Q34619384-2213A2E1-9AEA-4629-88E9-EC4F2A26087C

Q34619384-35AC13A6-8298-43B4-BCB5-7059977DF458

Q34619384-3CA31DA0-9800-457C-85D1-35E80EE15086

Q34619384-3D7DDAC9-A16E-4D27-A005-722E1CE4F6A0

P304

Q34619384-659EAF36-A8DE-485D-BBB4-C44E667B2565

P31

Q34619384-16FAF0C6-63F0-4425-954B-81C160F99D27

P356

Q34619384-D5914843-6AA4-493B-A9DD-994659373F14

P433

Q34619384-A0B5D9E6-6D93-46E1-8DB5-193813C93160

P478

Q34619384-16094E96-0BED-4D1F-A7B0-13036D1C8EDE

P577

Q34619384-87C0975C-290F-43D8-98FF-0D65EBE50A50

P5875

Q34619384-4B8726D2-A192-4DFC-ADB1-526842ECC722

P698

Q34619384-9E4EC0F0-69AA-4E24-87AA-712ACF8F9712

P356

J.1440-1746.2002.02777.X

P1433

Journal of Gastroenterology and Hepatology

P1476

Hepatitis C advances in antiviral therapy: what is accepted treatment now?

@en

P2093

John G McHutchison

http://www.w3.org/2001/XMLSchema#string

P2860

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis.

The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity.

Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.

Hepatitis C virus resistance to antiviral therapy.

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.

Modeling therapeutic benefit in the midst of uncertainty: therapy for hepatitis C.

P304

431-441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1440-1746.2002.02777.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11386386

http://www.w3.org/2001/XMLSchema#string

P698

11982724

http://www.w3.org/2001/XMLSchema#string